Cutaneous melanoma

被引：14

作者：

Rutkowski, Piotr ^{[1
]}

Wysocki, Piotr J. ^{[2
,3
]}

Nasierowska-Guttmejer, Anna ^{[4
,5
]}

Jeziorski, Arkadiusz ^{[6
]}

Wysocki, Wojciech M. ^{[7
]}

Kalinka, Ewa ^{[8
]}

Switaj, Tomasz ^{[1
]}

Kozak, Katarzyna ^{[1
]}

Kaminska-Winciorek, Grazyna ^{[9
,10
]}

Czarnecka, Anna M. ^{[1
]}

Kosela-Paterczyk, Hanna ^{[1
]}

Wisniewski, Piotr ^{[11
]}

Szumera-Cieckiewicz, Anna ^{[11
,12
]}

Zdzienicki, Marcin ^{[1
]}

Cybulska-Stopa, Bozena ^{[13
]}

Ziobro, Marek ^{[13
]}

Fijuth, Jacek ^{[14
]}

Kawecki, Andrzej ^{[15
]}

Rudnicka, Lidia ^{[16
]}

Owczarek, Witold ^{[17
]}

Krzakowski, Maciej ^{[18
]}

机构：

[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Melanoma & Soft Tissue & Bone Sarcomas, Warsaw, Poland

[2] Univ Hosp Cracow, Acad Dept Oncol, Krakow, Poland

[3] Jagiellonian Univ Cracow, Acad Dept Oncol, Krakow, Poland

[4] Minist Internal Affairs Warsaw, Cent Clin Hosp, Pathomorphol Unit, Warsaw, Poland

[5] Lazarski Univ Warsaw, Fac Med, Warsaw, Poland

[6] Med Univ Lodz, Dept Oncol Surg, Dept Oncol Surg 2, Reg Multidisciplinary M Kopernik Mem Oncol & Trau, Lodz, Poland

[7] Andrzej Frycz Modrzewski Krakow Univ AFMKU, Dept Surg, Fac Med & Hlth Sci, Krakow, Poland

[8] Polish Mother Mem Hlth Inst Lodz, Dept Oncol, Lodz, Poland

[9] Maria Sklodowska Curie Natl Res Inst Oncol, Branch Gliwice, Gliwice, Poland

[10] Dept Marrow Transplantat & Oncohaematol, Gliwice, Poland

[11] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Pathol & Lab Diagnost, Warsaw, Poland

[12] Inst Hematol & Transfus Med Warsaw, Dept Hematol Diagnost, Warsaw, Poland

[13] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Clin Oncol, Cracow Branch, Krakow, Poland

[14] Med Univ Lodz, Radiotherapy Unit, Lodz, Poland

[15] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Head & Neck Canc, Warsaw, Poland

[16] Warsaw Med Univ, Christ Child Mem Acad Hosp Warsaw, Warsaw, Poland

[17] Cent Acad Hosp MOD Warsaw, Mil Med Inst, Warsaw, Poland

[18] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Lungs & Thorac Canc, Warsaw, Poland

来源：

ONCOLOGY IN CLINICAL PRACTICE | 2020年 / 16卷 / 04期

关键词：

melanoma; diagnosis; therapy; immunotherapy; anti-PD-1; anti-CTLA-4; BRAF; MEK; sentinel lymph node biopsy; ADVANCED BRAF(V600)-MUTANT MELANOMA; DABRAFENIB PLUS TRAMETINIB; LYMPH-NODE DISSECTION; STAGE-III MELANOMA; OPEN-LABEL; METASTATIC MELANOMA; COMBINED NIVOLUMAB; DOUBLE-BLIND; IMPROVED SURVIVAL; ADJUVANT THERAPY;

D O I：

10.5603/OCP.2020.0021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

According to the authors and editors, this report contains the most justified principles of diagnostic and therapeutic procedures prepared considering the scientific value of evidence and category of recommendations. These principles should always be interpreted in the context of an individual clinical situation. The recommendations do not always correspond to the current reimbursement rules in Poland. In case of doubt, the current possibilities of reimbursement of individual procedures should be established. 1. The quality of scientific evidence I - Scientific evidence obtained from well-designed and conducted randomized clinical trials or meta-analyses of randomized clinical trials II - Scientific evidence obtained from well-designed and conducted prospective observational studies (non-randomized cohort studies) III - Scientific evidence obtained from retrospective observational studies or case-control studies IV - Scientific evidence obtained from clinical experiences and/or experts, opinions 2. Category of recommendations A - Indications confirmed unambiguously and absolutely useful in clinical practice B - Indications probable and potentially useful indications in clinical practice C - Indications determined individually. Copyright © 2020 Via Medica.

引用

页码：163 / 182

页数：20

共 66 条

[1] Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Andtbacka, Robert H. I.
Kaufman, Howard L.
Collichio, Frances
Amatruda, Thomas
Senzer, Neil
Chesney, Jason
Delman, Keith A.
Spitler, Lynn E.
Puzanov, Igor
Agarwala, Sanjiv S.
Milhem, Mohammed
Cranmer, Lee
Curti, Brendan
Lewis, Karl
Ross, Merrick
Guthrie, Troy
Linette, Gerald P.
Daniels, Gregory A.
Harrington, Kevin
Middleton, Mark R.
Miller, Wilson H., Jr.
Zager, Jonathan S.
Ye, Yining
Yao, Bin
Li, Ai
Doleman, Susan
VanderWalde, Ari
Gansert, Jennifer
Coffin, Robert S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) : 2780 - U98
[2] [Anonymous], 2020, CUTANEOUS MELANOMA V
[3] [Anonymous], NOWOTWORY J ONCOLOGY
[4] Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Ascierto, Paolo A.
McArthur, Grant A.
Dreno, Brigitte
Atkinson, Victoria
Liszkay, Gabrielle
Di Giacomo, Anna Maria
Mandala, Mario
Demidov, Lev
Stroyakovskiy, Daniil
Thomas, Luc
de la Cruz-Merino, Luis
Dutriaux, Caroline
Garbe, Claus
Yan, Yibing
Wongchenko, Matthew
Chang, Ilsung
Hsu, Jessie J.
Koralek, Daniel O.
Rooney, Isabelle
Ribas, Antoni
Larkin, James
[J]. LANCET ONCOLOGY, 2016, 17 (09) : 1248 - 1260
[5] Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, Charles M.
Gershenwald, Jeffrey E.
Soong, Seng-jaw
Thompson, John F.
Atkins, Michael B.
Byrd, David R.
Buzaid, Antonio C.
Cochran, Alistair J.
Coit, Daniel G.
Ding, Shouluan
Eggermont, Alexander M.
Flaherty, Keith T.
Gimotty, Phyllis A.
Kirkwood, John M.
McMasters, Kelly M.
Mihm, Martin C., Jr.
Morton, Donald L.
Ross, Merrick I.
Sober, Arthur J.
Sondak, Vernon K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6199 - 6206
[6] Ballo NT, 2004, ONCOLOGY-NY, V18, P99
[7] Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
Burmeister, Bryan H.
Henderson, Michael A.
Ainslie, Jill
Fisher, Richard
Di Iulio, Juliana
Smithers, B. Mark
Hong, Angela
Shannon, Kerwin
Scolyer, Richard A.
Carruthers, Scott
Coventry, Brendon J.
Babington, Scott
Duprat, Joao
Hoekstra, Harald J.
Thompson, John F.
[J]. LANCET ONCOLOGY, 2012, 13 (06) : 589 - 597
[8] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Chapman, Paul B.
Hauschild, Axel
Robert, Caroline
Haanen, John B.
Ascierto, Paolo
Larkin, James
Dummer, Reinhard
Garbe, Claus
Testori, Alessandro
Maio, Michele
Hogg, David
Lorigan, Paul
Lebbe, Celeste
Jouary, Thomas
Schadendorf, Dirk
Ribas, Antoni
O'Day, Steven J.
Sosman, Jeffrey A.
Kirkwood, John M.
Eggermont, Alexander M. M.
Dreno, Brigitte
Nolop, Keith
Li, Jiang
Nelson, Betty
Hou, Jeannie
Lee, Richard J.
Flaherty, Keith T.
McArthur, Grant A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) : 2507 - 2516
[9] Chiarion-Sileni V, 2013, J CLIN ONCOL, V31
[10] BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma
Cybulska-Stopa, Bozena
Rogala, Pawel
Czarnecka, Anna M.
Galus, Lukasz
Dziura, Robert
Rajczykowski, Marcin
Kubiatowski, Tomasz
Wisniewska, Magdalena
Gega-Czarnota, Adrianna
Teterycz, Pawel
Ziobro, Marek
Suwinski, Rafal
Mackiewicz, Jacek
Rutkowski, Piotr
[J]. MELANOMA RESEARCH, 2020, 30 (05) : 465 - 471

← 1 2 3 4 5 6 7 →